The Hong Kong government’s HK$62 billion (US$8 billion) investment fund is teaming up with a medical group co-founded by the ...

BCI devices are on display at the 2nd China Brain-Computer Interfaces Conference held in Wuhan, Central China's Hubei ...

Neuboron Medical Group (Neuboron ... Through continuous technological innovation and clinical exploration, Neuboron has not only set a benchmark in China's BNCT field but also made significant ...

Breast cancer remains a major global health challenge, with treatment strategies varying widely across regions. The continuous development of new therapies, combined with the pressing need to ...

A 10% tariff on goods from China, and proposed 25% tariffs on goods from Mexico and Canada, is jolting a healthcare industry that relies heavily on imported medical devices and supplies.

In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited ('CMS” or the 'Group”) has been included in ...

Baird Medical's presence at NASIT 2025 reaffirmed its commitment to advancing patient care through innovation ... expansion goals in the United States, China, or other markets; (2) changes ...

one of the largest private hospital chains by revenue in mainland China. Leung said the firm would promote commercialisation of Hong Kong medical innovations in the bay area, while also helping ...